Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sphingosine Kinase Type 2 Is a Putative BH3-only Protein That Induces Apoptosis*
Hong Liu ,
Rachelle E. Toman ,
Sravan K. Goparaju ,
Michael Maceyka ,
Victor E. Nava ¶,
Heidi Sankala ,
Shawn G. Payne ||,
Meryem Bektas ,
Isao Ishii **,
Jerold Chun ,
Sheldon Milstien ||, and
Sarah Spiegel
Department of Biochemistry, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298-0614, Interdisciplinary Program in Neuroscience and Department of Biochemistry, Georgetown University Medical Center, Washington, D. C. 20007, ¶Laboratory of Pathology, NCI, National Institutes of Health, Bethesda, Maryland 20892, **Department of Molecular Genetics, National Institute of Neuroscience, Tokyo 187-8502, Japan, Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, ||Laboratory of Cellular and Molecular Regulation, National Institute of Mental Health, Bethesda, Maryland 20892
Abstract:
There are two isoforms of sphingosine kinase (SphK) that catalyzethe formation of sphingosine 1-phosphate, a potent sphingolipidmediator. Whereas SphK1 stimulates growth and survival, herewe show that SphK2 enhanced apoptosis in diverse cell typesand also suppressed cellular proliferation. Apoptosis was precededby cytochrome c release and activation of caspase-3. SphK2-inducedapoptosis was independent of activation of sphingosine 1-phosphatereceptors. Sequence analysis revealed that SphK2 contains a9-amino acid motif similar to that present in BH3-only proteins,a pro-apoptotic subgroup of the Bcl-2 family. As with otherBH3-only proteins, co-immunoprecipitation demonstrated thatSphK2 interacted with Bcl-xL. Moreover, site-directed mutationof Leu-219, the conserved leucine residue present in all BH3domains, markedly suppressed SphK2-induced apoptosis. Hence,the apoptotic effect of SphK2 might be because of its putativeBH3 domain.
Received for publication April 29, 2003.
Revision received June 18, 2003.
* This work was supported by National Institutes of Health GrantsCA61774 (to S. S.) and in part by MH01723 (to J. C.). The costsof publication of this article were defrayed in part by thepayment of page charges. This article must therefore be herebymarked "advertisement" in accordance with 18 U.S.C. Section1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 804-828-9330; Fax: 804-828-8999; E-mail: sspiegel{at}vcu.edu.
The editors suggest the following Related Resources on Science sites:
BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate.
N. Takasugi, T. Sasaki, K. Suzuki, S. Osawa, H. Isshiki, Y. Hori, N. Shimada, T. Higo, S. Yokoshima, T. Fukuyama, et al. (2011)
J. Neurosci.
31, 6850-6857
|Abstract »|Full Text »|PDF »
Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640.
J. W. Antoon, M. D. White, W. D. Meacham, E. M. Slaughter, S. E. Muir, S. Elliott, L. V. Rhodes, H. B. Ashe, T. E. Wiese, C. D. Smith, et al. (2010)
Endocrinology
151, 5124-5135
|Abstract »|Full Text »|PDF »
ATP-independent glucose stimulation of sphingosine kinase in rat pancreatic islets.
L. D. Mastrandrea, S. M. Sessanna, A. Del Toro, and S. G. Laychock (2010)
J. Lipid Res.
51, 2171-2180
|Abstract »|Full Text »|PDF »
Regulating survival and development in the retina: key roles for simple sphingolipids.
N. P. Rotstein, G. E. Miranda, C. E. Abrahan, and O. L. German (2010)
J. Lipid Res.
51, 1247-1262
|Abstract »|Full Text »|PDF »
Restoring Endocrine Response in Breast Cancer Cells by Inhibition of the Sphingosine Kinase-1 Signaling Pathway.
O. Sukocheva, L. Wang, E. Verrier, M. A. Vadas, and P. Xia (2009)
Endocrinology
150, 4484-4492
|Abstract »|Full Text »|PDF »
A Novel Mitochondrial Sphingomyelinase in Zebrafish Cells.
T. Yabu, A. Shimuzu, and M. Yamashita (2009)
J. Biol. Chem.
284, 20349-20363
|Abstract »|Full Text »|PDF »
FHL-2 Suppresses VEGF-Induced Phosphatidylinositol 3-Kinase/Akt Activation via Interaction With Sphingosine Kinase-1.
H. Hayashi, H. Nakagami, Y. Takami, H. Koriyama, M. Mori, K. Tamai, J. Sun, K. Nagao, R. Morishita, and Y. Kaneda (2009)
Arterioscler Thromb Vasc Biol
29, 909-914
|Abstract »|Full Text »|PDF »
Sphingosine kinase regulation and cardioprotection.
Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons.
N. Hagen, P. P. Van Veldhoven, R. L. Proia, H. Park, A. H. Merrill Jr., and G. van Echten-Deckert (2009)
J. Biol. Chem.
284, 11346-11353
|Abstract »|Full Text »|PDF »
Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation.
S. Nemoto, M. Nakamura, Y. Osawa, S. Kono, Y. Itoh, Y. Okano, T. Murate, A. Hara, H. Ueda, Y. Nozawa, et al. (2009)
J. Biol. Chem.
284, 10422-10432
|Abstract »|Full Text »|PDF »
Differential regulation of sphingosine kinases 1 and 2 in lung injury.
R. Wadgaonkar, V. Patel, N. Grinkina, C. Romano, J. Liu, Y. Zhao, S. Sammani, J. G. N. Garcia, and V. Natarajan (2009)
Am J Physiol Lung Cell Mol Physiol
296, L603-L613
|Abstract »|Full Text »|PDF »
Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.
C.-C. Yeh, H. Li, D. Malhotra, M.-C. Huang, B.-Q. Zhu, E. J. Goetzl, D. A. Vessey, J. S. Karliner, and M. J. Mann (2009)
Am J Physiol Heart Circ Physiol
296, H1193-H1199
|Abstract »|Full Text »|PDF »
Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells.
S. E. Schnitzer, A. Weigert, J. Zhou, and B. Brune (2009)
Mol. Cancer Res.
7, 393-401
|Abstract »|Full Text »|PDF »
A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.
A. J. Snider, T. Kawamori, S. G. Bradshaw, K. A. Orr, G. S. Gilkeson, Y. A. Hannun, and L. M. Obeid (2009)
FASEB J
23, 143-152
|Abstract »|Full Text »|PDF »
Thematic Review Series: Sphingolipids. Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.
Caspase Cleavage of HER-2 Releases a Bad-like Cell Death Effector.
A. M. Strohecker, F. Yehiely, F. Chen, and V. L. Cryns (2008)
J. Biol. Chem.
283, 18269-18282
|Abstract »|Full Text »|PDF »
Sphingosine Kinase 1 Is Up-regulated during Hypoxia in U87MG Glioma Cells: ROLE OF HYPOXIA-INDUCIBLE FACTORS 1 AND 2.
V. Anelli, C. R. Gault, A. B. Cheng, and L. M. Obeid (2008)
J. Biol. Chem.
283, 3365-3375
|Abstract »|Full Text »|PDF »
Involvement of Sphingosine Kinase 2 in p53-Independent Induction of p21 by the Chemotherapeutic Drug Doxorubicin.
H. M. Sankala, N. C. Hait, S. W. Paugh, D. Shida, S. Lepine, L. W. Elmore, P. Dent, S. Milstien, and S. Spiegel (2007)
Cancer Res.
67, 10466-10474
|Abstract »|Full Text »|PDF »
Cutting Edge: Modulation of Intestinal Autoimmunity and IL-2 Signaling by Sphingosine Kinase 2 Independent of Sphingosine 1-Phosphate.
E. T. Samy, C. A. Meyer, P. Caplazi, C. L. Langrish, J. M. Lora, H. Bluethmann, and S. L. Peng (2007)
J. Immunol.
179, 5644-5648
|Abstract »|Full Text »|PDF »
A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.
Z.-Q. Jin, J. Zhang, Y. Huang, H. E. Hoover, D. A. Vessey, and J. S. Karliner (2007)
Cardiovasc Res
76, 41-50
|Abstract »|Full Text »|PDF »
Protein Kinase D-mediated Phosphorylation and Nuclear Export of Sphingosine Kinase 2.
G. Ding, H. Sonoda, H. Yu, T. Kajimoto, S. K. Goparaju, S. Jahangeer, T. Okada, and S.-i. Nakamura (2007)
J. Biol. Chem.
282, 27493-27502
|Abstract »|Full Text »|PDF »
(Dihydro)ceramide Synthase 1 Regulated Sensitivity to Cisplatin Is Associated with the Activation of p38 Mitogen-Activated Protein Kinase and Is Abrogated by Sphingosine Kinase 1.
J. Min, A. Mesika, M. Sivaguru, P. P. Van Veldhoven, H. Alexander, A. H. Futerman, and S. Alexander (2007)
Mol. Cancer Res.
5, 801-812
|Abstract »|Full Text »|PDF »
The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing.
V. Serriere-Lanneau, F. Teixeira-Clerc, L. Li, M. Schippers, W. de Wries, B. Julien, J. Tran-Van-Nhieu, S. Manin, K. Poelstra, J. Chun, et al. (2007)
FASEB J
21, 2005-2013
|Abstract »|Full Text »|PDF »
Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by FTY720 Analogues.
A. S. Don, C. Martinez-Lamenca, W. R. Webb, R. L. Proia, E. Roberts, and H. Rosen (2007)
J. Biol. Chem.
282, 15833-15842
|Abstract »|Full Text »|PDF »
Activation of Sphingosine Kinase-1 Mediates Inhibition of Vascular Smooth Muscle Cell Apoptosis by Hyperglycemia.
Sphingosine Kinase Type 2 Activation by ERK-mediated Phosphorylation.
N. C. Hait, A. Bellamy, S. Milstien, T. Kordula, and S. Spiegel (2007)
J. Biol. Chem.
282, 12058-12065
|Abstract »|Full Text »|PDF »
Deletion of the Sphingosine Kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
R. Tao, J. Zhang, D. A. Vessey, N. Honbo, and J. S. Karliner (2007)
Cardiovasc Res
74, 56-63
|Abstract »|Full Text »|PDF »
Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives.
S. Spiegel and S. Milstien (2007)
J. Biol. Chem.
282, 2125-2129
|Full Text »|PDF »
FHL2/SLIM3 Decreases Cardiomyocyte Survival by Inhibitory Interaction With Sphingosine Kinase-1.
J. Sun, G. Yan, A. Ren, B. You, and J. K. Liao (2006)
Circ. Res.
99, 468-476
|Abstract »|Full Text »|PDF »
Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate.
A. Weigert, A. M. Johann, A. von Knethen, H. Schmidt, G. Geisslinger, and B. Brune (2006)
Blood
108, 1635-1642
|Abstract »|Full Text »|PDF »
The Calmodulin-binding Site of Sphingosine Kinase and Its Role in Agonist-dependent Translocation of Sphingosine Kinase 1 to the Plasma Membrane.
C. M. Sutherland, P. A. B. Moretti, N. M. Hewitt, C. J. Bagley, M. A. Vadas, and S. M. Pitson (2006)
J. Biol. Chem.
281, 11693-11701
|Abstract »|Full Text »|PDF »
Essential Role for Sphingosine Kinases in Neural and Vascular Development.
K. Mizugishi, T. Yamashita, A. Olivera, G. F. Miller, S. Spiegel, and R. L. Proia (2005)
Mol. Cell. Biol.
25, 11113-11121
|Abstract »|Full Text »|PDF »
SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism.
M. Maceyka, H. Sankala, N. C. Hait, H. Le Stunff, H. Liu, R. Toman, C. Collier, M. Zhang, L. S. Satin, A. H. Merrill Jr., et al. (2005)
J. Biol. Chem.
280, 37118-37129
|Abstract »|Full Text »|PDF »
Involvement of N-terminal-extended Form of Sphingosine Kinase 2 in Serum-dependent Regulation of Cell Proliferation and Apoptosis.
T. Okada, G. Ding, H. Sonoda, T. Kajimoto, Y. Haga, A. Khosrowbeygi, S. Gao, N. Miwa, S. Jahangeer, and S.-i. Nakamura (2005)
J. Biol. Chem.
280, 36318-36325
|Abstract »|Full Text »|PDF »
Immunohistochemical Distribution of Sphingosine Kinase 1 in Normal and Tumor Lung Tissue.
K. R. Johnson, K. Y. Johnson, H. G. Crellin, B. Ogretmen, A. M. Boylan, R. A. Harley, and L. M. Obeid (2005)
Journal of Histochemistry & Cytochemistry
53, 1159-1166
|Abstract »|Full Text »|PDF »
Role of Sphingosine Kinase 2 in Cell Migration toward Epidermal Growth Factor.
N. C. Hait, S. Sarkar, H. Le Stunff, A. Mikami, M. Maceyka, S. Milstien, and S. Spiegel (2005)
J. Biol. Chem.
280, 29462-29469
|Abstract »|Full Text »|PDF »
The S1P2 Receptor Negatively Regulates Platelet-Derived Growth Factor-Induced Motility and Proliferation.
S. K. Goparaju, P. S. Jolly, K. R. Watterson, M. Bektas, S. Alvarez, S. Sarkar, L. Mel, I. Ishii, J. Chun, S. Milstien, et al. (2005)
Mol. Cell. Biol.
25, 4237-4249
|Abstract »|Full Text »|PDF »
Sphingosine Kinase Activity and Sphingosine-1 Phosphate Production in Rat Pancreatic Islets and INS-1 Cells: Response to Cytokines.
L. D. Mastrandrea, S. M. Sessanna, and S. G. Laychock (2005)
Diabetes
54, 1429-1436
|Abstract »|Full Text »|PDF »
Arabidopsis Sphingosine Kinase and the Effects of Phytosphingosine-1-Phosphate on Stomatal Aperture.
S. Coursol, H. Le Stunff, D. V. Lynch, S. Gilroy, S. M. Assmann, and S. Spiegel (2005)
Plant Physiology
137, 724-737
|Abstract »|Full Text »|PDF »
Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling.
S. M. Pitson, P. Xia, T. M. Leclercq, P. A.B. Moretti, J. R. Zebol, H. E. Lynn, B. W. Wattenberg, and M. A. Vadas (2005)
J. Exp. Med.
201, 49-54
|Abstract »|Full Text »|PDF »
Sphingosine Kinase Regulates the Sensitivity of Dictyostelium discoideum Cells to the Anticancer Drug Cisplatin.
J. Min, D. Traynor, A. L. Stegner, L. Zhang, M. H. Hanigan, H. Alexander, and S. Alexander (2005)
Eukaryot. Cell
4, 178-189
|Abstract »|Full Text »|PDF »
Sphingosine Kinase 1 (SPHK1) Is Induced by Transforming Growth Factor-{beta} and Mediates TIMP-1 Up-regulation.
M. Yamanaka, D. Shegogue, H. Pei, S. Bu, A. Bielawska, J. Bielawski, B. Pettus, Y. A. Hannun, L. Obeid, and M. Trojanowska (2004)
J. Biol. Chem.
279, 53994-54001
|Abstract »|Full Text »|PDF »
Sphingosine Kinase Mediates Activation of Extracellular Signal-Related Kinase and Akt by Respiratory Syncytial Virus.
M. M. Monick, K. Cameron, L. S. Powers, N. S. Butler, D. McCoy, R. K. Mallampalli, and G. W. Hunninghake (2004) 30, 844-852
|Abstract »|Full Text »|PDF »
Transactivation of Sphingosine-1-Phosphate Receptors by Fc{varepsilon}RI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis.
P. S. Jolly, M. Bektas, A. Olivera, C. Gonzalez-Espinosa, R. L. Proia, J. Rivera, S. Milstien, and S. Spiegel (2004)
J. Exp. Med.
199, 959-970
|Abstract »|Full Text »|PDF »
Point-Counterpoint of Sphingosine 1-Phosphate Metabolism.